Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SBFM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0898 +35.30%
on 09/10/21
0.1350 -10.00%
on 08/27/21
+0.0050 (+4.29%)
since 08/20/21
3-Month
0.0898 +35.30%
on 09/10/21
0.1780 -31.74%
on 06/23/21
-0.0405 (-25.00%)
since 06/21/21
52-Week
0.0100 +1,115.00%
on 11/09/20
0.3140 -61.31%
on 05/26/21
+0.1015 (+507.50%)
since 09/21/20

Most Recent Stories

More News
Sunshine Biopharma's Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern

Sunshine Biopharma Inc. (OTC Pink: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it mapped the mutations...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Opens Twitter Account For Increased Shareholder Engagement

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, is pleased to announce that we have opened...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has received additional...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has succeeded in...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today confirmed that its COVID-19 mice study...

SBFM : 0.1215 (+0.91%)
Novel Anti-Cancer Drugs Permeate the Marketplace

, /PRNewswire/ -- The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with...

SBFM : 0.1215 (+0.91%)
VSTM : 2.86 (+1.78%)
TRIL : 17.29 (-0.06%)
IMGN : 5.93 (+3.49%)
SRNE : 8.00 (+0.38%)
Sunshine Biopharma's Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has elucidated the...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has paid off $250,000...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Reports Improved Cash Position in 2021Q1 Filing

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, announced that it has filed its 2021 first...

SBFM : 0.1215 (+0.91%)
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application

Sunshine Biopharma Inc. (OTC PINK: "SBFM"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has timely filed...

SBFM : 0.1215 (+0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.1273
2nd Resistance Point 0.1252
1st Resistance Point 0.1233
Last Price 0.1215
1st Support Level 0.1193
2nd Support Level 0.1172
3rd Support Level 0.1153

See More

52-Week High 0.3140
Fibonacci 61.8% 0.1979
Fibonacci 50% 0.1620
Fibonacci 38.2% 0.1261
Last Price 0.1215
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar